Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Feb 5;6:6046. doi: 10.1038/ncomms7046.

PMID:
25651891
[PubMed - in process]
Free PMC Article
2.

Association between Skin and Joint Involvement in Patients with Psoriatic Arthritis Treated with Adalimumab: Analysis of Data from a German Non-Interventional Study.

Thaçi D, Behrens F, Greger G, Burkhardt H, Gnann H, Schopf R, Wittig BM.

Dermatology. 2015 Jan 27. [Epub ahead of print]

PMID:
25632852
[PubMed - as supplied by publisher]
3.

Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature.

Behrens F, Cañete JD, Olivieri I, van Kuijk AW, McHugh N, Combe B.

Rheumatology (Oxford). 2014 Oct 27. pii: keu415. [Epub ahead of print]

PMID:
25349441
[PubMed - as supplied by publisher]
4.

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.

Behrens F, Tak PP, Ostergaard M, Stoilov R, Wiland P, Huizinga TW, Berenfus VY, Vladeva S, Rech J, Rubbert-Roth A, Korkosz M, Rekalov D, Zupanets IA, Ejbjerg BJ, Geiseler J, Fresenius J, Korolkiewicz RP, Schottelius AJ, Burkhardt H.

Ann Rheum Dis. 2014 Feb 17. doi: 10.1136/annrheumdis-2013-204816. [Epub ahead of print]

PMID:
24534756
[PubMed - as supplied by publisher]
Free Article
5.

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.

Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaçi D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R, Alvarez D.

J Am Acad Dermatol. 2013 Nov;69(5):729-35. doi: 10.1016/j.jaad.2013.07.023. Epub 2013 Aug 24.

PMID:
23981683
[PubMed - indexed for MEDLINE]
6.

Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?

Gramsch C, Göricke SL, Behrens F, Zimmer L, Schadendorf D, Krasny A, Forsting M, Schlamann MU.

Eur Radiol. 2013 Sep;23(9):2622-7. doi: 10.1007/s00330-013-2857-3. Epub 2013 May 14.

PMID:
23670820
[PubMed - indexed for MEDLINE]
7.

Development and validation of a new disease activity score in 28 joints-based treatment response criterion for rheumatoid arthritis.

Behrens F, Tony HP, Alten R, Kleinert S, Scharbatke EC, Köhm M, Gnann H, Tams J, Greger G, Burkhardt H.

Arthritis Care Res (Hoboken). 2013 Oct;65(10):1608-16. doi: 10.1002/acr.22037.

PMID:
23609999
[PubMed - indexed for MEDLINE]
8.

Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis.

Apel M, Uebe S, Bowes J, Giardina E, Korendowych E, Juneblad K, Pasutto F, Ekici AB, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Padyukov L, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A, Hüffmeier U.

Arthritis Rheum. 2013 May;65(5):1224-31. doi: 10.1002/art.37885.

PMID:
23401011
[PubMed - indexed for MEDLINE]
Free Article
9.

[Personalized medicine in cytokine-targeted therapy].

Behrens F, Köhm M.

Z Rheumatol. 2013 Feb;72(1):41-8. doi: 10.1007/s00393-011-0886-3. German.

PMID:
23392600
[PubMed - indexed for MEDLINE]
10.

Leflunomide in psoriatic arthritis: results from a large European prospective observational study.

Behrens F, Finkenwirth C, Pavelka K, Štolfa J, Šipek-Dolnicar A, Thaçi D, Burkhardt H.

Arthritis Care Res (Hoboken). 2013 Mar;65(3):464-70. doi: 10.1002/acr.21848.

PMID:
23042698
[PubMed - indexed for MEDLINE]
11.

Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization.

Böhm B, Burkhardt H, Uebe S, Apel M, Behrens F, Reis A, Hüffmeier U.

Arthritis Res Ther. 2012 Apr 18;14(2):R84. doi: 10.1186/ar3807.

PMID:
22513239
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Diagnosis and therapy of early psoriatic arthritis].

Köhm M, Behrens F.

Z Rheumatol. 2012 Jan;71(1):46-52. doi: 10.1007/s00393-011-0896-1. German.

PMID:
22286355
[PubMed - indexed for MEDLINE]
13.

Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus.

Giardina E, Hüffmeier U, Ravindran J, Behrens F, Lepre T, McHugh NJ, Korendowych E, Burkhardt H, Novelli G, Reis A.

Arthritis Rheum. 2011 Dec;63(12):3801-6. doi: 10.1002/art.30591.

PMID:
22127698
[PubMed - indexed for MEDLINE]
Free Article
14.

Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.

Abdulghani M, Al Sheik A, Alkhawajah M, Ammoury A, Behrens F, Benchikhi H, Benkaidali I, Doss N, El Gendy A, Mokhtar I, Odendaal D, Raboobee N, Thaçi D, Weiss R, Whitaker D.

J Int Med Res. 2011;39(5):1573-88. Review.

PMID:
22117959
[PubMed - indexed for MEDLINE]
15.

Increased levels of anti-glycan antibodies in patients with cystic fibrosis.

Hirche TO, Stein J, Hirche H, Hausmann J, Wagner TO, Behrens F, Schröder O.

Eur J Med Res. 2011 Sep 12;16(9):385-90.

PMID:
22024437
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).

Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O; Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.

J Rheumatol. 2011 Nov;38(11):2419-27. doi: 10.3899/jrheum.110344. Epub 2011 Oct 1. Review.

PMID:
21965635
[PubMed - indexed for MEDLINE]
17.

Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.

Denton CP, Avouac J, Behrens F, Furst DE, Foeldvari I, Humbert M, Huscher D, Kowal-Bielecka O, Matucci-Cerinic M, Nash P, Opitz CF, Pittrow D, Rubin LJ, Seibold JR, Distler O.

Arthritis Res Ther. 2011 Jun 20;13(3):114. doi: 10.1186/ar3346.

PMID:
21699746
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.

Behrens F, Koehm M, Burkhardt H.

Curr Opin Rheumatol. 2011 May;23(3):282-7. doi: 10.1097/BOR.0b013e328344fddb. Review.

PMID:
21427581
[PubMed - indexed for MEDLINE]
19.

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.

Hüffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, Juneblad K, Apel M, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Lascorz J, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Herold C, Steffens M, Klareskog L, Wienker TF, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A.

Nat Genet. 2010 Nov;42(11):996-9. doi: 10.1038/ng.688. Epub 2010 Oct 17.

PMID:
20953186
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

An improved algorithm for automatic detection of saccades in eye movement data and for calculating saccade parameters.

Behrens F, Mackeben M, Schröder-Preikschat W.

Behav Res Methods. 2010 Aug;42(3):701-8. doi: 10.3758/BRM.42.3.701.

PMID:
20805592
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk